Pharmaceutical industry overview
The economic slowdown, growing demand, and constant need for innovation have prompted pharmaceutical companies to expand into new product categories and market segments. Staying ahead of technological developments in this industry is crucial and requires access to sophisticated methodologies and in-depth market data essential for business success.
Infiniti Research has extensive experience working with leading healthcare and pharma companies. Some of the research projects we have conducted for our clients in the pharmaceutical industry include patient satisfaction and feedback analysis, new product development research, product evaluation, product positioning, market segmentation research, and market opportunity analysis. Our solutions for the pharma industry comprise a unique combination of advanced research methodologies, technology, and domain expertise to deliver intelligence and empower clients with the actionable, precise information needed to understand market dynamics and enhance decisions.
Our pharmaceutical market intelligence solutions help our clients to focus on the needs of the growing patient population by offering detailed insights on different patient groups.
We provide advanced pharmaceutical market intelligence solutions that deliver repeatable and sustainable results for our clients.
We offer solutions to enhance clinical trial success, designed just as precisely as the treatment it is intended to test.
Our expertise spans the entire KOL ecosystem, including KOL identification, KOL profiling and mapping.
Drug Discovery and Development
We offer ongoing support to enhance the drug development process right from discovery to launch.
We employ integrated research methodologies to uncover new solutions to diagnostic challenges facing pharma companies.
Generics and Prescription Drugs
Our pharmaceutical market intelligence solutions help you get to the root of drug pricing challenges by offering in-depth, actionable insights.
Our pharmaceutical market intelligence solutions and innovative research methodologies have helped some of the world’s leading pharma companies, drug manufacturers, pharma R&D firms, and suppliers make informed decisions to drive outcomes and improve the quality of services.
Speak to one of our pharma market experts to find out how we can help you.
Understanding Structural and Strategic Barriers to Entry in Global Markets
An existing market player might deliberately lower prices or take over a potential rival by purchasing sufficient shares to gain an edge in the market. As with other methods that further reinforce the barriers, regulators may prevent this to reduce competition.
Industry Best Practices for Manufacturing Companies
Manufacturing continues to evolve, opening up a whole new world of possibilities for progressive manufacturing companies with an eye on innovation. However, keeping up with the rapid transformations in the post-pandemic world presents a new...
Why Conducting Market Analysis is Crucial for Business Success
Starting a new business or developing a new product requires businesses to conduct an in-depth market analysis. Understanding market needs provides insights for developing and launching your product. Too often, businesses launch a new product...
Market Opportunity Analysis Helped an Industrial Heating Systems Manufacturer Build a Detailed Five-year Business Development Strategy
Explore our latest case study to understand how our market intelligence team’s market opportunity analysis aided an industrial heating systems manufacturer devise a robust five-year business growth strategy.
Agile Innovation in Healthcare: The New Business Imperative
Healthcare payers and providers face numerous challenges due to a dynamic business landscape. Thus, an organization’s ability to respond and adapt quickly to change has gained increased importance. Companies that have managed to crack the...
Value-based Healthcare Administration and the Rise of Medical Wearable Devices
Spiralling cost is admittedly a key issue for the healthcare sector, increasingly forcing the industry toward an outcome-based (value-based) delivery model in which money changes hands based on improved patient health outcomes and this applies to just about everyone’s paycheck: doctors, nurses, midwives, medical imaging facilities, radiologists, labs, hospitals, and urgent care clinics. With more data, comes new responsibilities. As intelligent medical devices start “talking” to each other, there is a risk of cybercriminals potentially hijacking patients’ personally identifiable information (PII) to commit fraud. The risk is very real, and robust security measures are certainly required to secure against damning data breaches. Moreover, the US Food & Drug Administration (FDA) holds medical device manufacturers responsible for identifying risks, including those related to cybersecurity, associated with their devices.